31st October 2019 Farmantra will be organising a panel discussion titled : Winning Strategies and Uncertainties in Life Sciences. The Panelists are : Stephan Christgau : Founding Partner, EIR Ventures and Former Senior Partner, Novo Seeds Raúl Martín-Ruiz, Partner, Ysios…
14th February 2019 In this workshop, we will explore how a good early stage valuation is actually a mix of building right narratives backed by numbers. We will also bust a few myths such as “early stage products cannot be…
30th November 2018 Panelists GuillemLaporta – Principal, Ysios Capital, Spain Esteban Pombo-Villar – CEO, Targimmune, Switzerland Christofer Adding – COO, Attgeno, Sweden Raúl Insa – CEO, SOM Biotech, Spain Keynote Speakers : Jordi Naval, CEO of Biocat, Spain Edoardo Negroni,…
29th November 2018 In the pursuit of enhancing value to the Biotech community, Farmantra brought together the Biotech companies and the investors through a panel discussion moderated by Saurabh Mishra, the managing partner of Farmantra. The Panel comprising successful Biotech…
5th November 2018 LABIOTECH.eu published ‘Going Public: A Guide for European Biotechs’ which leveraged Farmantra’s expertise on exit strategies and IPO through Nasdaq vs Euronext. Read More
25th October 2018 Farmantra organized a workshop ‘Early stage valuation: Narratives and Numbers’ in association with Danish Biotech association where Saurabh Mishra discussed: Pre-money, pricing, and valuation Negotiation strategy with investors How narratives play important role in valuation Risks and…
Another interesting ‘Valuation’ session for Farmantra at Karolinska institute where Saurabh Mishra, Managing partner, Farmantra S.L delivered valuable information to the delightful entrepreneurs of KI DRIVE. Takeaways : Early stage valuation is storytelling backed by numbers. Know your audience when…
14th March 2018 Aleap, Norway’s largest community for health startups invited Farmantra to give a talk on early stage valuation and the challenges faced by young Biotechs where Farmantra delivered valuable insights on early stage companies and the role of…